Transgene Biotek Ltd share price logo

Transgene Biotek Share Price

BSE: 526139

Small Cap

Healthcare Sector

₹2.23

+0.12

(+5.69%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Transgene Biotek Stock Performance

as on April 6, 2026 at 7:48 pm IST

  • Day's Low

    Day's High

    ₹2.15
    ₹2.28
    downward going graph

    3.59%

    Downside

    2.24%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1.83
    ₹5.26
    downward going graph

    17.94%

    Downside

    135.87%

    Upside

    downward going graph

Transgene Biotek share price movements today

Previous Close
₹2.11
Open
₹2.15
Volume
17.31K
Upper Circuit
₹2.53
Lower Circuit
₹1.69
Day's Low - High
₹2.15 - ₹2.28
52 Week Low - High
₹1.83 - ₹5.26

Transgene Biotek Historical Returns

1 Month Return
-25.7 %
3 Month Return
-26.22 %
1 Year Return
-42.51 %
3 Year Return
-14.23 %
5 Year Return
-60.11 %

Transgene Biotek Fundamentals

as on April 6, 2026 at 2:18 pm IST

Market Cap

₹15.99 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-8.44

Return on capital employed (ROCE)

0

Industry PE ratio

44.99

Beta (LTM)

0.71

P/B Ratio

-3.35

Dividend Yield

0

PEG Ratio

38.36

Quarterly Earnings Growth YOY

311.11

EPS (TTM)

-0.09

Sector

Healthcare

Book Value

1.32

Technical Analysis

Bearish

View Technical Analysis

Transgene Biotek Stock Valuation

as on April 6, 2026 at 2:18 pm IST

Transgene Biotek in the last 5 years

  • Overview

  • Trends

Lowest (-227.67x)

December 31, 2024

Today (-8.44x)

April 2, 2026

Industry (44.99x)

April 2, 2026

Highest (13.23x)

October 8, 2018

LowHigh

Today’s Price to Earnings Ratio: -8.44x

Transgene Biotek Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Transgene Biotek with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Transgene Biotek Ltd image
Transgene Biotek Ltd
NA15.99-12.02%0.96-1NA
Jeevan Scientific Technology Ltd image
Jeevan Scientific Technology Ltd
NA132.620.49%0.65-246
Shalby Ltd image
Shalby Ltd
BUY1,505.665.87%0.6711,086
Family Care Hospitals Ltd image
Family Care Hospitals Ltd
NA15.07-16.56%0.00-457
Centenial Surgical Suture Ltd image
Centenial Surgical Suture Ltd
NA28.0919.84%0.00-253
See all

Transgene Biotek Stock’s Investor Sentiment and Interest

Search interest for Transgene Biotek Ltd Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Transgene Biotek Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
0.1
0.05
0.05
0.05
0.05
0.06
0.08
0.08
0.05
0.05
0.05
Other Income
0.04
0.04
0.04
0.05
0.65
0.04
0.04
0.04
-
-
-
Total Income
0.14
0.09
0.09
0.1
0.7
0.1
0.12
0.12
0.05
0.05
0.05
Expenses
0.22
0.17
0.15
0.31
0.46
0.14
0.17
0.62
0.19
0.13
0.11
Operating Profit
-0.12
-0.12
-0.1
-0.26
-0.41
-0.08
-0.09
-0.54
-0.14
-0.08
-0.06
Operating Profit Margin %
-120%
-240%
-200%
-520%
-820%
-133.33%
-112.5%
-675%
-280%
-160%
-120%
Profit Before Interest, Tax and Depreciation
-0.08
-0.08
-0.06
-0.22
0.24
-0.03
-0.05
-0.5
-0.14
-0.07
-0.05
Interest
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.19
0.25
0.26
0.27
Depreciation
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.05
0.05
0.05
Profit Before Tax
-0.13
-0.13
-0.11
-0.27
0.2
-0.07
-0.09
-0.71
-0.44
-0.38
-0.37
Profit After Tax
-0.13
-0.13
-0.12
-0.27
0.2
-0.07
-0.09
-0.71
-0.43
-0.39
-0.37
Total Net profit including share of profit / Loss from associate company
-0.13
-0.13
-0.12
-0.27
0.2
-0.07
-0.09
-0.71
-0.43
-0.39
-0.37
EPS
-0.02
-0.02
-0.02
-0.04
0.03
-0.01
-0.01
-0.09
-0.06
-0.05
-0.05
Actual EPS
-0.02
-0.02
-0.02
-0.04
0.03
-0.01
-0.01
-0.09
-0.06
-0.05
-0.05
Adjusted EPS
-0.02
-0.02
-0.02
-0.04
0.03
-0.01
-0.01
-0.09
-0.06
-0.05
-0.05
Diluted EPS
-0.02
-0.02
-0.02
-0.04
0.03
-0.01
-0.01
-0.09
-0.06
-0.05
-0.05

Transgene Biotek Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
0.07
-
0.17
0.09
0.06
0.23
0.26
Other Income
2.04
0.18
0.27
0.21
0.18
0.18
0.78
Total Income
2.11
0.18
0.44
0.3
0.23
0.42
1.04
Expenses
0.76
0.87
0.7
0.55
1.11
0.85
1.38
Operating Profit
-0.69
-0.87
-0.53
-0.46
-1.05
-0.62
-1.12
Operating Profit Margin %
-985.71%
0%
-311.76%
-511.11%
-1750%
-269.57%
-430.77%
Profit Before Interest, Tax and Depreciation
1.35
-0.68
-0.26
-0.25
-0.88
-0.43
-0.34
Interest
0.25
0.38
0.27
0.23
0.18
0.13
0.24
Depreciation
9.89
9.9
9.91
9.92
4.95
0.09
0.09
Profit Before Tax
-8.79
-10.96
-10.44
-10.4
-6.01
-0.65
-0.67
Profit After Tax
-8.79
-10.96
-10.43
-10.4
-6.01
-0.66
-0.68
Total Net profit including share of profit / Loss from associate company
-8.79
-10.96
-10.43
-10.4
-6.01
-0.66
-0.68
EPS
-1.2
-1.45
-1.38
-1.37
-0.79
-0.09
-0.09
Actual EPS
-1.2
-1.45
-1.38
-1.37
-0.79
-0.09
-0.09
Adjusted EPS
-1.2
-1.45
-1.38
-1.37
-0.79
-0.09
-0.09
Diluted EPS
-1.2
-1.45
-1.38
-1.37
-0.79
-0.09
-0.09

Transgene Biotek Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
6.47
0.02
-0.63
-1.74
0.14
0.01
0.1
-
-
1.2
Cash Flow from Investing Activities
-
-
3.05
1.81
-
-
-0.1
-0.01
-
-
Cash Flow from Financing Activities
-
-
-2.37
-
-0.2
-
-
-
-
0.78
Net Cash Flow
-
0.02
0.05
-
-0.06
-0.01
-
-0.01
-
0.28

Transgene Biotek Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
Public
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
Total Outstanding Shares
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
Total Shareholders
11,342
11,360
12,220
12,426
12,766
12,963
13,307
13,583
13,475
13,461
13,545

Transgene Biotek Corporate Actions

View detailed summary of the earnings and dividend history of Transgene Biotek.

  • Transgene Biotek Ltd Earnings Results

    Transgene Biotek Ltd’s net profit fell -311.11% since last year same period to ₹0.37Cr in the Q3 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 5.13% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Transgene Biotek Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -0.71 Cr → -0.37 Cr (in ₹), with an average increase of 26.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Take Solutions Ltd has given 417.7% return, outperforming this stock by 460.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 21.68% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Take Solutions Ltd has given 161.7% return, outperforming this stock by 175.9%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 70.04% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Transgene Biotek stock has moved down by -25.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 0.12 Cr → 0.05 Cr (in ₹), with an average decrease of 19.4% per quarter

About Transgene Biotek Ltd

Transgene Biotek is a public limited company incorporated in Mar.90, engaged in research and development and manufacturing of medical reagents for diagnosis of diseases. It exports nutrients to African countries, Russia, China, Malaysia and the Philippines. The company is implementing a new project at Bollaram Anrich Industrial Area costing Rs.30 crore to set up a new manufacturing facility. The plant will work on four types of products – oral delivery of proteins and peptides, DNA vaccines, fusion proteins and biotherapeutics. The project will be funded by way of preferential offer to Batterymarch Financial Management in USA and other financial institutions.

Revenue: ₹0.05Cr as on December 2025 (Q3 FY26)
Net Profit: ₹0.37Cr as on December 2025 (Q3 FY26)
Chairperson Name: K Koteswara Rao
OrganisationTransgene Biotek Ltd
IndustryHealthcare
CEOK Koteswara Rao
E-voting on sharesClick here to vote

FAQs

What is Transgene Biotek share price today?

Transgene Biotek share price today stands at ₹2.23 as on . Transgene Biotek share today touched a day high of ₹2.28 and a low of ₹2.15.

What is the 52 week high and 52 week low range for Transgene Biotek share?

Transgene Biotek touched a 52 week high of ₹5.26 and a 52 week low of ₹1.83. Transgene Biotek share price today i.e. is trending at ₹2.23, which is -57.60% down from its 52 week high and 21.86% up from its 52 week low.

What is Transgene Biotek's market capitalisation today?

Transgene Biotek market capitalisation is ₹15.99 Cr as on .

How to buy Transgene Biotek shares?

To buy Transgene Biotek shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 526139 or Transgene Biotek Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Transgene Biotek shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Transgene Biotek trading volume today?

Transgene Biotek trading volume is 17.31K as on . This means that 17.31K shares of Transgene Biotek were bought and sold on the stock market during today's trading session.